Y-Intercept (HK)’s Minerva Neurosciences NERV Stock Holding History

Y-Intercept (HK)’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$359K	Buy	+64,687	New	+$351K	0.01%	1414
2021 Q3	–	Sell	-1,266	Closed	-$23K	–	822
2021 Q2	$23K	Buy	+1,266	New	+$27.3K	0.01%	581

Other funds holding NERV

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Y-Intercept (HK)'s NERV Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Minerva Neurosciences (NERV) in Q2 2026: 64,687 shares worth $359K. The stake represents 0.01% of the portfolio and ranks #1414 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in NERV as recently as Q2 2021.

Y-Intercept (HK) first reported a position in NERV in Q2 2021 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

Y-Intercept (HK) held 64,687 shares of Minerva Neurosciences worth $359K as of Q2 2026.
Minerva Neurosciences was a new Y-Intercept (HK) position in Q2 2026.
Minerva Neurosciences made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1414 holding.
Y-Intercept (HK) first reported a position in Minerva Neurosciences in Q2 2021 and has held it in 2 quarters since.
4 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.